CarlsonALSherrJLShulmanDI, et al. Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2022;24(3):178-189.
2.
DovcKBattelinoTBeckRW, et al. Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. Diabetes Technol Ther. 2022;24(11):848-852.
3.
GómezAMHenaoDCMuñozOM, et al. Temporary target versus suspended insulin infusion in patients with type 1 diabetes using the MiniMed 780G advanced closed-loop hybrid system during aerobic exercise: a randomized crossover clinical trial. Diabetes Technol Ther. 2024;26(11):823-828.
4.
GrosmanBRoyALintereurL, et al. A peek under the hood: explaining the MiniMed™ 780G algorithm with meal detection technology. Diabetes Technol Ther. 2024;26(S3):17-23.